Massachusetts General Hospital customised the MetaVision Anaesthesia Information Management System (AIMS) to ensure that anaesthesia providers complete a separate quality assurance data collection program. As a result, the hospital increased their ability to capture adverse events by 92%.

A study published by MetaVision users at University Hospital of Lausanne (CHUV) shows that using CIS facilitates glucose control, improves nutritional monitoring and the quality of nutrition, and reduces nurse workload. MetaVision has been operational in the hospital since 1999, and over the years it was installed in the hospital’s entire ICU (32 beds), surgical ICU, cardiac surgery, intermediate care and Division of Neonatology.

A study at Universitaire Ziekenhuizen Leuven assessed the impact of a blood glucose (BG) alert generated by MetaVision on tight glycaemic control (TGC) in the ICU. The study found that the alert was able to further improve the quality of BG control, as shown by a reduced mean BG per patient, a lower glycaemic penalty index and hyperglycaemic index, and a lower number of patients with hyperglycaemia, without increasing the need for blood sampling. According to the study, “The finding that a simple electronic alert system can improve the quality and safety of TGC, even in a setting where protocols for TGC were already in place at a high level of experience, is striking.”

A study from Anesthesiology Clinics reviews the impact of AIMS with decision support at various hospitals, including a clinical improvement at Massachusetts General Hospital using MetaVision.

A study recently published in the European Journal of Anaesthesiology shows a dramatic increase in adherence to prophylaxis administration guidelines using MetaVision, at OLVG hospital. Using MetaVision decision support tools, the Hospital was able to increase timely delivery of both dexamethasone and granisetron from 39% to 79%. The study concluded “decision support is effective in improving administration and timing of PONV prophylaxis medication”.

A new study of critically ill patients at Lehigh Valley Hospital has found significantly reduced mortality rates, after implementing a health IT bundle including MetaVision. The hospital used MetaVision as the ICU’s electronic medical record, and MVcentral for telemonitoring, to achieve intensivist bedside coverage 24/7. LVH published that after implementing MetaVision, among other technologies, mortality fell from 21.4% to 14.7% (a reduction of 31.3%).

A study at the Papworth Hospital, Cambridge, UK, showed that after the implementation of MetaVision in their 25-bed ICU, all issues of legibility, completeness and traceability were eliminated, increasing the percentage of correctly prescribed drugs from 53% to 100%. For example, MetaVision reduced dose errors from 11.7% in handwritten prescriptions to 0% post-implementation and increased the traceability of prescribers from 31% on handwritten prescriptions to 100% after deployment.

A study at the VU University Medical Centre showed that MetaVision and its decision support tools allow for significantly improved early delivery of nutrition in the ICU. After installing MetaVision, the percentage of patients with adequate nutrients delivered by day 4 in the ICU increased from 30.2% to 56.5%, in accordance with ICU guidelines. Recent literature shows that nutrition protocol management and guideline adherence is critical to shortening ICU stays and reducing patient mortality.

Research at the paediatric ICU at the Schneider Children’s Medical Center, Israel, shows that prescription errors and potential adverse drug events were significantly reduced through the use of MetaVision's decision support capabilities. Specifically, adverse drug events were reduced by 72%, while medication prescription errors fell from 5.5% to a mere 0.7%. This shows the extent to which MetaVision can prevent weight-based calculation errors, which are of particular significance in paediatrics.

The rate of alarm reactivation at baseline (Stage I) was 22%, increased to 63% (Stage II), and again to 83% during Stage III (P < 0.001). The spontaneous alarm reactivation rate before the appearance of the electronic reminder on the anaesthesia information management system screen increased from 19% at Stage II to 42% at stage III (P < 0.001).